AnaZyme has developed the first assay for the diagnosis of shock. Shock is a serious condition which frequently leads to multi-organ failure and death. Shock is the second leading cause of death in hospitals in the US. This assay is based on biomarkers are measured from both liquid blood samples and from exhaled breath.
Cuéntanos a qué tipo de público quieres llegar
Hospitals and Medical Professionals
We're open to any creative effort but the logo needs to look professional. It should be a logo that portrays the idea of a life-saving product.